Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|1|1|1-12

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.1, Iss.1, 2008-01, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An approach to the development of novel antihypertensive drugs: potential role of sodium pump inhibitors

By Goto A.   Yamada K.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 6, 1998-06 ,pp. : 201-204

Elsevier

Access to resources Recommend Favorite

Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs

By Corson T.W.   Woo K.K.   Li P.P.   Warsh J.J.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes

By Prada Patricia O  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R   Goekjian Peter G  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite